Design and Discovery of Functionally Selective Serotonin 2C (5-HT2c) Receptor Agonists

被引:30
|
作者
Cheng, Jianjun [1 ,5 ]
McCorvy, John D. [2 ]
Giguere, Patrick M. [2 ,6 ]
Zhu, Hu [2 ,7 ]
Kenakin, Terry [3 ,4 ]
Roth, Bryan L. [2 ]
Kozikowski, Alan P. [1 ]
机构
[1] Univ Illinois, Dept Med Chem & Pharmacognosy, Coll Pharm, Drug Discovery Program, Chicago, IL 60612 USA
[2] Univ N Carolina, Sch Med, Natl Inst Mental Hlth, Psychoact Drug Screening Program, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Sch Med, Div Pharmacol, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Sch Med, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA
[5] ShanghaiTech Univ, iHuman Inst, 99 Haike Rd, Shanghai 201210, Peoples R China
[6] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada
[7] NCATS, Div Preclin Innovat, 9800 Med Ctr Dr, Rockville, MD 20850 USA
关键词
MELATONIN RECEPTORS; TRANSDUCTION; IDENTIFICATION; LIGANDS; POTENT; DRUG;
D O I
10.1021/acs.jmedchem.6b01194
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
On the basis of the structural similarity of our previous 5-HT2c agonists with the melatonin receptor agonist tasimelteon and the putative biological cross-talk between serotonergic and melatonergic systems, a series of new (2,3-dihydro)benzofuran-based compounds were designed and synthesized. The compounds were evaluated for their selectivity toward 5-HT2A, 5-HT2B, and 5HT(2c) receptors in the calcium flux assay with the ultimate goal to generate selective 5-HT2c agonists. Selected compounds were studied for their functional selectivity by comparing their transduction efficiency at the G protein signaling pathway versus beta-arrestin recruitment. The most functionally selective compound (+)-7e produced weak beta-arrestin recruitment and also demonstrated less receptor desensitization compared to serotonin in both calcium flux and phosphoinositide (PI) hydrolysis assays. We report for the first time that selective 5-HT2c agonists possessing weak beta-arrestin recruitment can produce distinct receptor desensitization properties.
引用
收藏
页码:9866 / 9880
页数:15
相关论文
共 50 条
  • [21] Indazoles as selective 5-HT2C receptor agonists for the treatment of obesity.
    Dawson, CE
    Adams, DR
    Bentley, JM
    Benwell, K
    Bickerdike, MJ
    Cliffe, IA
    Duncton, MAJ
    Hamlyn, RJ
    Kennett, GA
    Knight, T
    Malcolm, C
    Misra, A
    Roffey, JR
    Vickers, S
    Dourish, CT
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U67 - U67
  • [22] Dibenzofuranylethylamines as 5-HT2A/2C Receptor Agonists
    Yempala, Thirumal
    Brea, Jose
    Isabel Loza, Maria
    Matthies, Douglas J.
    Zapata-Torres, Gerald
    Cassels, Bruce K.
    ACS OMEGA, 2020, 5 (05): : 2260 - 2266
  • [23] Agonists of the serotonin 5-HT2C receptor:: Preclinical and clinical progression in multiple diseases
    Wacker, Dean A.
    Miller, Keith J.
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2008, 11 (04) : 438 - 445
  • [24] Pleiotropic behavior of 5-HT2A and 5-HT2C receptor agonists
    Berg, KA
    Maayani, S
    Goldfarb, J
    Clarke, WP
    ADVANCES IN SEROTONIN RECEPTOR RESEARCH: MOLECULAR BIOLOGY, SIGNAL TRANSDUCTION, AND THERAPEUTICS, 1998, 861 : 104 - 110
  • [25] Discovery of Novel Oleamide Analogues as Brain-Penetrant Positive Allosteric Serotonin 5-HT2C Receptor and Dual 5-HT2C/5-HT2A Receptor Modulators
    Chen, Jianping
    Garcia, Erik J.
    Merritt, Christina R.
    Zamora, Joshua C.
    Bolinger, Andrew A.
    Pazdrak, Konrad
    Stafford, Susan J.
    Mifflin, Randy C.
    Wold, Eric A.
    Wild, Christopher T.
    Chen, Haiying
    Anastasio, Noelle C.
    Cunningham, Kathryn A.
    Zhou, Jia
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (14) : 9992 - 10009
  • [26] Discovery of 4-undecylpiperidine-2-carboxamides as selective positive allosteric modulators of the serotonin (5-HT) 5-HT2C receptor
    Wold, Eric
    Wild, Christopher
    McAllister, Carrie
    Crawford, Claudia
    Ding, Ye
    Anastasio, Noelle
    Fox, Robert
    Stutz, Sonja
    Hartley, Rachel
    Chen, Haiying
    White, Mark
    Cunningham, Kathryn
    Zhou, Jia
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [27] Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures
    Venzi, Marcello
    David, Francois
    Bellet, Joachim
    Cavaccini, Anna
    Bombardi, Cristiano
    Crunelli, Vincenzo
    Di Giovanni, Giuseppe
    NEUROPHARMACOLOGY, 2016, 108 : 292 - 304
  • [28] Evaluation of the Abuse Potential of Lorcaserin, a Serotonin 2C (5-HT2C) Receptor Agonist, in Recreational Polydrug Users
    Shram, M. J.
    Schoedel, K. A.
    Bartlett, C.
    Shazer, R. L.
    Anderson, C. M.
    Sellers, E. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (05) : 683 - 692
  • [29] Identification of a new polymorphism in the 3′-untranslated region of the human serotonin receptor 2C (5-HT2C) gene
    Song, HR
    Gu, A
    Schanen, NC
    MOLECULAR GENETICS AND METABOLISM, 1999, 66 (03) : 224 - 227
  • [30] Discovery and development of 5-HT2C receptor agonists for obesity: is there light at the end of the tunnel?
    Miller, Keith J.
    Wacker, Dean A.
    FUTURE MEDICINAL CHEMISTRY, 2010, 2 (12) : 1761 - 1775